← Back
$VIR All transactions

Vir Biotechnology, Inc.

▼ SELL 10b5-1 Plan

$ Value

$20K

Shares

3,586

Price

$5

Filed

Jul 17

Insider

Name

Eisner Mark

Title

EVP and Chief Medical Officer

CIK

0001834161

Roles

Officer

Transaction Details

Transaction Date

2025-07-17

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

104,618

Footnotes

Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units. | Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 5, 2024. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.41 to $5.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Filing Info

Accession No.

0001628280-25-035269

Form Type

4

Issuer CIK

0001706431

Eisner Mark's History

Date Ticker Type Value
2025-07-17 VIR $20K
2025-07-15 VIR $37K

Other Insiders at VIR (90d)

Insider Bought Sold Last
SATO VICKI L $369K 2026-04-01
De Backer Marianne
President and CEO
$664K 2026-04-06
Sabatini Brent
SVP, Chief Accounting Officer
$70K 2026-03-23